Showing results (11-20 of 331) with videos related to
Sort By:
Pageof 34
The International Journal on Drug Policy|January 1, 2008
Opioid dependent patients' experiences of and attitudes towards having their injecting sites examinedAdam R Winstock, Maria Nittis, Gilbert Whitton, et al.Drug and Alcohol Review|April 21, 2009
Satisfaction guaranteed? What clients on methadone and buprenorphine think about their treatmentAnnie Madden, Toby Lea, Nicky Bath, et al.The Medical Journal of Australia|August 4, 2009
Injection of medications used in opioid substitution treatment in Australia after the introduction of a mixed partial agonist-antagonist formulationLouisa Degenhardt, Briony K Larance, James R Bell, et al.CNS Drugs|June 2, 2009
Prescription of heroin for the management of heroin dependence: current statusNicholas LintzerisDrug and Alcohol Review|August 22, 2002
Buprenorphine dosing regime in the management of out-patient heroin withdrawalNicholas LintzerisAddiction (Abingdon, England)|February 1, 2012
Controlling new drugs under marketing regulationsBrendan Hughes, Adam R WinstockDrug and Alcohol Dependence|January 8, 2013
Synthetic cannabis: a comparison of patterns of use and effect profile with natural cannabis in a large global sampleAdam R Winstock, Monica J BarrattJournal of Psychopharmacology (Oxford, England)|November 5, 2019
Nitrous oxide causes peripheral neuropathy in a dose dependent manner among recreational usersAdam R Winstock, Jason A FerrisHuman Psychopharmacology|July 25, 2013
The 12-month prevalence and nature of adverse experiences resulting in emergency medical presentations associated with the use of synthetic cannabinoid productsAdam R Winstock, Monica J BarrattPageof 34